Clinical Trial Update: Mycophenolate for Pulmonary Sarcoidosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating mycophenolate for pulmonary sarcoidosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Sarcoidosis

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Pulmonary Sarcoidosis | Phase 3 | Status: TERMINATED